Will Johnson & Johnson (JNJ) Earnings Move the Dow?

With dozens of companies having already reported quarterly results, we’re now in the heart of earnings season. The key to making smart investment decisions with stocks releasing their quarterly reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed, knee-jerk decision.

Johnson & Johnson (NYSE:JNJ)Let’s turn to Johnson & Johnson (NYSE:JNJ). With its 11% gain outpacing the Dow Jones Industrials in 2012, the health care conglomerate hopes that 2013 will mark a new chapter in which it can get past some of the challenges of recent years. Let’s take an early look at what’s been happening with Johnson & Johnson over the past quarter and what we’re likely to see in its quarterly report next Tuesday morning.

Stats on Johnson & Johnson

Analyst EPS Estimate $1.17
Change From Year-Ago EPS 3.5%
Revenue Estimate $17.67 billion
Change From Year-Ago Revenue 8.7%
Earnings Beats in Past 4 Quarters 4

Source: Yahoo Finance.

Will Johnson & Johnson move the markets?
Projections for J&J’s fourth-quarter earnings have stayed quite stable over the past few months, with the consensus earnings-per-share forecast barely budging. That resilience has contributed to strong stock performance, with shares rising about 5% since mid-October.

The big challenge that J&J has faced throughout the past several years has been a surge in product recalls and other negative news. With an average of almost one recall per month in 2012, J&J failed to make much progress on that score last year, and the repeated failures have damaged consumer confidence in the company’s products. One thing to look for in this quarter’s report is any sign that problems are creeping up among J&J’s more consumer-facing segments.

But J&J may be able to gain from the woes of robotic surgical giants MAKO Surgical and Intuitive Surgical, both of which have come under fire as growth in the industry starts to slow. If robotic medical devices become more of a niche market and less a cutting-edge technology, then J&J’s more traditional device business may be better able to take advantage.

One question J&J management might get to address this quarter is whether J&J would be better off splitting up. With fellow health-care conglomerate Abbott Laboratories (NYSE:ABT) having spun off its AbbVie proprietary pharmaceutical business into a separately traded entity, some would argue that J&J could benefit from having its pharmaceuticals, medical-device, and consumer products divisions all set free to operate independently.

J&J has every chance to put its best foot forward to start 2013. If it can’t reverse some of its more troubling trends, though, 2013 could be another tough year for the health-care giant.

The article Will Johnson & Johnson Earnings Move the Dow? originally appeared on Fool.com.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Intuitive Surgical, Johnson & Johnson, and MAKO Surgical. The Motley Fool owns shares of Intuitive Surgical, Johnson & Johnson, and MAKO Surgical.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!